{
    "ticker": "ICAD",
    "name": "iCAD, Inc.",
    "description": "iCAD, Inc. is a recognized leader in the field of cancer detection and therapy solutions, specializing in advanced imaging and software technologies. Founded in 1984 and headquartered in Nashua, New Hampshire, iCAD focuses on enhancing the accuracy of radiologists' diagnoses through innovative artificial intelligence (AI) and machine learning algorithms. The company is well-known for its flagship products, including the iCAD ProFound AI, which utilizes deep learning to assist in the detection of breast cancer in mammography images. This technology significantly improves workflow efficiency and accuracy, empowering healthcare professionals to better serve their patients. iCAD also offers solutions for oncology treatments, including the Xoft Axxent Electronic Brachytherapy System, which provides a targeted radiation treatment option for various cancer types while minimizing exposure to surrounding healthy tissue. With a strong commitment to improving patient outcomes and advancing the field of medical imaging, iCAD is at the forefront of innovation, collaborating with healthcare providers and researchers to develop next-generation diagnostic tools. The company\u2019s mission is to provide clinicians with the tools they need to detect cancer earlier and treat it more effectively.",
    "industry": [
        "Healthcare",
        "Medical Devices"
    ],
    "headquarters": "Nashua, New Hampshire, USA",
    "founded": "1984",
    "website": "https://www.icadmed.com",
    "ceo": "M. Kenneth Ferry",
    "social_media": {
        "twitter": "https://twitter.com/iCADMedical",
        "linkedin": "https://www.linkedin.com/company/icad-inc-/"
    },
    "investor_relations": "https://investors.icadmed.com",
    "key_executives": [
        {
            "name": "M. Kenneth Ferry",
            "position": "CEO"
        },
        {
            "name": "Sarah O'Brien",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Cancer Detection Solutions",
            "products": [
                "ProFound AI",
                "ProFound AI for Breast Density"
            ]
        },
        {
            "category": "Cancer Therapy Solutions",
            "products": [
                "Xoft Axxent Electronic Brachytherapy System"
            ]
        }
    ],
    "seo": {
        "meta_title": "iCAD, Inc. | Advanced Cancer Detection and Therapy Solutions",
        "meta_description": "Explore iCAD, Inc., a leader in cancer detection technology focused on improving diagnostic accuracy and treatment outcomes through innovative AI solutions.",
        "keywords": [
            "iCAD",
            "Cancer Detection",
            "Medical Imaging",
            "AI in Healthcare",
            "Brachytherapy",
            "ProFound AI"
        ]
    },
    "faq": [
        {
            "question": "What does iCAD specialize in?",
            "answer": "iCAD specializes in cancer detection and therapy solutions through advanced imaging and software technologies."
        },
        {
            "question": "Who is the CEO of iCAD?",
            "answer": "M. Kenneth Ferry is the CEO of iCAD, Inc."
        },
        {
            "question": "Where is iCAD headquartered?",
            "answer": "iCAD is headquartered in Nashua, New Hampshire, USA."
        },
        {
            "question": "What are iCAD's main products?",
            "answer": "iCAD's main products include ProFound AI for cancer detection and the Xoft Axxent Electronic Brachytherapy System for cancer therapy."
        },
        {
            "question": "When was iCAD founded?",
            "answer": "iCAD was founded in 1984."
        }
    ],
    "competitors": [
        "GE",
        "MDT",
        "VAR",
        "IQV"
    ],
    "related_stocks": [
        "ABBV",
        "JNJ",
        "PFE",
        "BMY"
    ]
}